PharmiWeb.com - Global Pharma News & Resources

Healthcare - Press Releases

Date Title Company
06-Jun-2024 Beckman Coulter Life Sciences Releases Innovative Assay to Quantify Antibody Aggregation Beckman Coulter Life Sciences
06-Jun-2024 Clinigen acquires boutique market access consultancy Ascenian to accelerate access to lifesaving treatments Clinigen
06-Jun-2024 KITE RECEIVES EUROPEAN MEDICINES AGENCY APPROVAL OF SAFETY MONITORING VARIATION FOR CAR T-CELL THERAPY PORTFOLIO Gilead Sciences
06-Jun-2024 CYCLE PHARMACEUTICALS ANNOUNCES ALL-CASH PROPOSAL TO ACQUIRE VANDA PHARMACEUTICALS FOR $8.00 PER SHARE Cycle Pharmaceuticals
05-Jun-2024 OrganaBio expands California CPC Services hub for sample processing and cryopreservation capabilities to support Big Pharma clinical trials OrganaBio
05-Jun-2024 Celerion Honored With Prestigious CRO Leadership Award for Ninth Consecutive Year Celerion
05-Jun-2024 Quell Therapeutics Advances QEL-001, its Multi-modular Engineered CAR-Treg Cell Therapy, into Efficacy Cohort of LIBERATE Phase 1/2 Trial in Liver Transplant Patients Quell Therapeutics
05-Jun-2024 OncoZenge participates in MASCC cancer care conference June 27-29 OncoZenge
05-Jun-2024 Grey Wolf Therapeutics Presents First Clinical Data for GRWD5769, a First-in-Class ERAP1 Inhibitor, at the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting Grey Wolf Therapeutics
05-Jun-2024 OncoHost Announces New Study on Biomarkers for Renal Cell Carcinoma OncoHost
05-Jun-2024 ENCOURAGING NEW DATA PRESENTED ON KITE’S YESCARTA (AXICABTAGENE CILOLECUEL) FOR RELAPSED/REFRACTORY CENTRAL NERVOUS SYSTEM LYMPHOMA Kite, a Gilead Company
05-Jun-2024 Brandon Capital Announces Sixth Fund with A$270 million (US$180 million) Initial Close to Drive Life Science Innovation Brandon Capital
05-Jun-2024 invoX Pharma Presents Positive Clinical Data from Phase 1 Study of FS222 in Patients with Advanced Solid Tumours at the 2024 American Society of Clinical Oncology Annual Meeting invoX Pharma
05-Jun-2024 Shionogi Expands Global Infectious Disease and Antimicrobial Research Operations to U.S. to Address Current and Emerging Health Threats Shionogi & Co., Ltd
05-Jun-2024 New WISH report to focus on the ethical management of AI in healthcare WORLD INNOVATION SUMMIT FOR HEALTH
05-Jun-2024 Scottish healthcare innovators urged to apply to NHS Clinical Entrepreneur Programme by InnoScot Health InnoScot Health
04-Jun-2024 Discover Cutting-Edge Medical Innovations and Global Healthcare Advancements at the Florida International Medical Expo (FIME) Florida International Medical Expo (FIME)
04-Jun-2024 Our children deserve better – HOYA Vision Care calls for urgent action to address childhood myopia Hoya Vision Care
03-Jun-2024 ENCOURAGING NEW DATA PRESENTED ON KITE’S YESCARTA (AXICABTAGENE CILOLECUEL) FOR RELAPSED/REFRACTORY CENTRAL NERVOUS SYSTEM LYMPHOMA Kite, a Gilead Company
03-Jun-2024 Lundbeck presents innovative first in human trial design of Lu AG13909 for potential treatment of congenital adrenal hyperplasia H. Lundbeck A/S